Palisade Bio Inc. (PALI) Financial Statements (2024 and earlier)

Company Profile

Business Address 7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,43212,38310,49510,5295,1155,787
Cash and cash equivalents12,43212,38310,49510,5295,1155,787
Receivables    11621358
Prepaid expense4345871,4101,400511363
Deferred costs112114    
Disposal group, including discontinued operation    835  
Other undisclosed current assets3501,649469   
Total current assets:13,32814,73312,37412,8815,6476,508
Noncurrent Assets
Operating lease, right-of-use asset198300109 204
Property, plant and equipment10103114190
Long-term investments and receivables      298
Due from related parties    298
Intangible assets, net (including goodwill)    147669764
Intangible assets, net (excluding goodwill)    147669764
Restricted cash and investments262626   
Other noncurrent assets490694   24
Other undisclosed noncurrent assets    1023 
Total noncurrent assets:7241,0301381689371,176
TOTAL ASSETS:14,05215,76312,51213,0496,5847,684
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,5292,3332,2972,322136 
Employee-related liabilities5112,322136 
Accounts payable6981,7591,323   
Accrued liabilities831574463   
Debt   87   
Disposal group, including discontinued operation    234  
Other liabilities      219
Other undisclosed current liabilities1,0576791126491,089833
Total current liabilities:2,5863,0122,4963,2061,2251,051
Noncurrent Liabilities
Long-term debt and lease obligation:     149 
Liabilities, other than long-term debt1532722,6517585584
Operating lease, liability90211  149
Business combination, contingent consideration, liability61     
Derivative instruments and hedges, liabilities2612,6517585584
Total noncurrent liabilities:1532722,65175233584
Total liabilities:2,7393,2845,1473,2811,4581,635
Equity
Equity, attributable to parent, including:11,31312,4797,3659,7685,1266,050
Preferred stock    2210
Common stock933014317339182
Additional paid in capital132,724121,637101,862247,836227,067219,482
Accumulated other comprehensive loss    (1)(6)(0)
Accumulated deficit    (238,242)(221,976)(213,624)
Other undisclosed equity, attributable to parent(121,504)(109,188)(94,640)   
Total equity:11,31312,4797,3659,7685,1266,050
TOTAL LIABILITIES AND EQUITY:14,05215,76312,51213,0496,5847,684

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues 250  1486260
Sublease income     86
Gross profit: 250  1486260
Operating expenses(13,320)(15,721)(41,854)(10,689)(8,647)(8,519)
Other undisclosed operating loss     (71) 
Operating loss:(13,070)(15,721)(41,854)(10,676)(8,632)(8,259)
Nonoperating income (expense)7701,46115,238(5,591)2803,335
Investment income, nonoperating    346879
Other nonoperating income78515847   
Interest and debt expense(15)(13)279(14)(9)(8)
Loss from continuing operations:(12,315)(14,273)(26,337)(16,281)(8,361)(4,932)
Loss before gain (loss) on sale of properties:(26,337)(16,281)(8,361)(4,932)
Net loss:(12,315)(14,273)(26,337)(16,281)(8,361)(4,932)
Other undisclosed net income (loss) attributable to parent1513(279)1498
Net loss attributable to parent:(12,300)(14,260)(26,616)(16,267)(8,352)(4,925)
Other undisclosed net loss available to common stockholders, basic(16)(288)    
Net loss available to common stockholders, basic:(12,316)(14,548)(26,616)(16,267)(8,352)(4,925)
Dilutive securities, effect on basic earnings per share   (5,119)   
Net loss available to common stockholders, diluted:(12,316)(14,548)(31,735)(16,267)(8,352)(4,925)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(12,315)(14,273)(26,337)(16,281)(8,361)(4,932)
Comprehensive loss:(12,315)(14,273)(26,337)(16,281)(8,361)(4,932)
Other undisclosed comprehensive income, net of tax, attributable to parent    1935
Comprehensive loss, net of tax, attributable to parent:(12,315)(14,273)(26,337)(16,261)(8,357)(4,928)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: